Conference Description
The Proteases, Inhibitors and Therapeutics GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
For 2026, the conference will place a special emphasis on the mechanisms, functions, and translational implications of proteases and their inhibitors, highlighting their roles in health, disease, and therapeutic innovation. Sessions will explore the latest advances in protease biology, the development of next-generation inhibitors, and the impact of these molecules on drug discovery and patient care. Emerging technologies for monitoring protease activity and novel strategies for targeting proteolysis will be featured, as those that have led to recent breakthroughs, in SARS-CoV-2 main protease inhibitors in infectious disease, cancer, and cardiovascular research. The program will showcase world-renowned experts in protease structure, function, and inhibition, whose work spans innovative analytical platforms, the dynamics of proteases in complex biological systems, and the translation of fundamental discoveries into impactful therapies. The conference continues its tradition of fostering interdisciplinary collaborations, welcoming new researchers, and supporting the growth of promising scientists. A dedicated seminar will accompany the 2026 meeting, focused on mentoring and attracting junior scientists, graduate students, and postdoctoral fellows to this vibrant field. Whether your interests are in basic enzyme biochemistry, structural and chemical biology, or translational drug discovery, this conference offers a unique environment to explore the exciting intersection of protease research and therapeutic innovation.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by September 24, 2025. Please check back for updates.
